NasdaqGM:PRCTMedical Equipment
PROCEPT BioRobotics (PRCT) Faces Lawsuit Scrutiny After Revenue Claims So Is It A Buying Opportunity
Recent securities class action filings against PROCEPT BioRobotics (PRCT) accuse the company of misleading investors on handpiece sales, undisclosed discount programs, and inflated revenue. The allegations are raising fresh questions around its reported growth, guidance cuts, and stock volatility.
See our latest analysis for PROCEPT BioRobotics.
The recent wave of lawsuits helps explain why PROCEPT BioRobotics has had a weak year to date, with the stock showing a 30 day share price return of...